Search details
1.
Complement component C1q is an immunological rheostat that regulates Fc:Fc[Formula: see text]R interactions.
Immunogenetics
; 75(4): 369-383, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37322230
2.
Anti-CD20 Antibody with Multimerized Fc Domains: A Novel Strategy To Deplete B Cells and Augment Treatment of Autoimmune Disease.
J Immunol
; 196(3): 1165-76, 2016 Feb 01.
Article
in English
| MEDLINE | ID: mdl-26695368
3.
Recombinant human IgG1 based Fc multimers, with limited FcR binding capacity, can effectively inhibit complement-mediated disease.
J Autoimmun
; 84: 97-108, 2017 Nov.
Article
in English
| MEDLINE | ID: mdl-28830653
4.
An ACE2-IgG4 Fc Fusion Protein Demonstrates Strong Binding to All Tested SARS-CoV-2 Variants and Reduced Lung Inflammation in Animal Models of SARS-CoV-2 and Influenza.
Pathog Immun
; 7(1): 104-121, 2022.
Article
in English
| MEDLINE | ID: mdl-36072571
5.
A recombinant human IgG1 Fc multimer designed to mimic the active fraction of IVIG in autoimmunity.
JCI Insight
; 4(2)2019 Jan 24.
Article
in English
| MEDLINE | ID: mdl-30674715
6.
Tumour antigen targeted monoclonal antibodies incorporating a novel multimerisation domain significantly enhance antibody dependent cellular cytotoxicity against colon cancer.
Eur J Cancer
; 49(15): 3344-52, 2013 Oct.
Article
in English
| MEDLINE | ID: mdl-23871153
7.
Fully recombinant IgG2a Fc multimers (stradomers) effectively treat collagen-induced arthritis and prevent idiopathic thrombocytopenic purpura in mice.
Arthritis Res Ther
; 14(4): R192, 2012 Aug 20.
Article
in English
| MEDLINE | ID: mdl-22906120
Results
1 -
7
de 7
1
Next >
>>